Skip to main content
logo
Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.605
-0.105 (-6.14%)
May 14, 2026, 1:17 PM EDT - Market open

Autolus Therapeutics Revenue

Autolus Therapeutics had revenue of $26.22M in the quarter ending March 31, 2026, with 191.89% growth. This brings the company's revenue in the last twelve months to $92.62M, up 927.90% year-over-year. In the year 2025, Autolus Therapeutics had annual revenue of $75.39M with 644.94% growth.

Revenue (ttm)
$92.62M
Revenue Growth
+927.90%
P/S Ratio
6.04
Revenue / Employee
$99,984
Employees
754
Market Cap
427.16M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202575.39M65.27M644.94%
Dec 31, 202410.12M8.42M496.00%
Dec 31, 20231.70M-4.68M-73.38%
Dec 31, 20226.38M4.87M323.23%
Dec 31, 20211.51M1.27M522.73%
Dec 31, 2020242.00K--
Dec 31, 2019---
Dec 31, 2018---
Sep 30, 2018---
Sep 30, 2017---
Sep 30, 2016---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Fulcrum Therapeutics80.00M
ADC Therapeutics79.18M
Prelude Therapeutics16.72M
Ovid Therapeutics7.12M
PureTech Health4.66M
Lyell Immunopharma31.00K
Revenue Rankings

AUTL News

More News